We work closely with patients to ensure their plan is safe, effective, and tailored to their unique needs
The prescription medication was formulated by Novo Nordisk and first received FDA approval for use as a type 2 diabetes treatment in December 5, 2017, resulting in the introduction of Ozempic as a once-weekly injectable GLP-1 receptor agonist designed to regulate blood sugar by enhancing insulin production
Finally, it was recently suggested that IGF-I has significant characteristics to be a good marker for the insulin resistance syndrome and risk of cardiovascular disease, since logistic regression analysis showed that each unit increase in log-transformed IGF-I concentrations was associated with a 90.5% reduction in the risk of metabolic syndrome[274]
Cinnamon effects on metabolic syndrome: a review based on its mechanisms
elegans in co-culture with Escherichia coli , possibly due to the gut microbiota-derived metabolite agmatine (Pryor et al., 2019)
Check with your health insurance plan to see if it is included on the formulary and what your cost-sharing would be before starting the medication, as they can become quite cost-prohibitive over time
